Ann Boriack-Sjodin

Ann Boriack-Sjodin joined Accent in October 2017 as Vice President of Molecular Discovery, bringing more than 20 years of drug discovery experience to the role. She has spent her industrial career using structural biology, biochemical and biophysical methods to advance drug discovery programs in a variety of therapeutic areas. Prior to joining Accent, she served as Senior Director, Lead Discovery at Epizyme, contributing to biochemical and structural characterization as well as the development of tool compounds for several protein methyltransferases. Ann has also worked at AstraZeneca, where she contributed to efforts in infectious disease and oncology, and Biogen Idec, where she contributed to both small molecule and biologic drug discovery programs. She is a member of the Penn Chemistry Scientific Advisory Committee at the University of Pennsylvania. Ann received a B.A. in chemistry from Harvey Mudd College, obtained her Ph.D. in biological chemistry from the University of Pennsylvania working with Dr. David Christianson and received postdoctoral training in the lab of Dr. John Kuriyan at The Rockefeller University.